Miguel A. Boarati, MD
Article
Six-Month Open-Label Follow-Up of Risperidone Long-Acting Injection Use in Pediatric Bipolar Disorder
May 2, 2013
The authors of this study describe the effects of RLAI as a short-term treatment agent in young patients with severe bipolar disorder symptomatology and nonadherence to prescribed oral medications....
